BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26858454)

  • 21. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.
    Menne J; Meier M; Park JK; Boehne M; Kirsch T; Lindschau C; Ociepka R; Leitges M; Rinta-Valkama J; Holthofer H; Haller H
    Kidney Int; 2006 Oct; 70(8):1456-62. PubMed ID: 16955103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ELMO1 variants and susceptibility to diabetic nephropathy in American Indians.
    Hanson RL; Millis MP; Young NJ; Kobes S; Nelson RG; Knowler WC; DiStefano JK
    Mol Genet Metab; 2010 Dec; 101(4):383-90. PubMed ID: 20826100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
    Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
    Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.
    Lo CS; Shi Y; Chang SY; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Diabetologia; 2015 Oct; 58(10):2443-54. PubMed ID: 26232095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
    Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
    Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.
    Chacko BK; Reily C; Srivastava A; Johnson MS; Ye Y; Ulasova E; Agarwal A; Zinn KR; Murphy MP; Kalyanaraman B; Darley-Usmar V
    Biochem J; 2010 Nov; 432(1):9-19. PubMed ID: 20825366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.
    Shike T; Gohda T; Tanimoto M; Kobayashi M; Makita Y; Funabiki K; Horikoshi S; Hirose S; Shirai T; Tomino Y
    Nephrol Dial Transplant; 2005 May; 20(5):879-85. PubMed ID: 15769825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
    Fujita H; Morii T; Fujishima H; Sato T; Shimizu T; Hosoba M; Tsukiyama K; Narita T; Takahashi T; Drucker DJ; Seino Y; Yamada Y
    Kidney Int; 2014 Mar; 85(3):579-89. PubMed ID: 24152968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.
    Kakoki M; Sullivan KA; Backus C; Hayes JM; Oh SS; Hua K; Gasim AM; Tomita H; Grant R; Nossov SB; Kim HS; Jennette JC; Feldman EL; Smithies O
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10190-5. PubMed ID: 20479236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.